Diligent Investors, LLC Abb Vie Inc. Transaction History

Diligent Investors, LLC

$369 Million
Q1 2024

A detailed history of Diligent Investors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Diligent Investors, LLC holds 8,574 shares of ABBV stock, worth $1.43 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

8,574

Previous 8,570 0.05%

Holding current value

$1.43 Million

Previous $1.33 Million 17.55%

% of portfolio

0.42%

Previous 0.39%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $639 - $728	4 Added 0.05%	8,574 $1.56 Million
Q4 2023 Jan 10, 2024	BUY	$137.6 - $154.97 $1,788 - $2,014	13 Added 0.15%	8,570 $1.33 Million
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $25,248 - $29,228	-189 Reduced 2.16%	8,557 $1.28 Million
Q2 2023 Jul 24, 2023	BUY	$132.51 - $164.9 $1,590 - $1,978	12 Added 0.14%	8,746 $1.18 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $1,590 - $1,831	11 Added 0.13%	8,734 $1.39 Million

Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $2,351 - $2,819	-17 Reduced 0.19%	8,723 $0
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $13,555 - $15,546	-101 Reduced 1.14%	8,740 $1.17 Million
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $1,376 - $1,749	10 Added 0.11%	8,841 $1.35 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $32,335 - $40,118	-245 Reduced 2.7%	8,831 $1.43 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $2,148 - $2,718	-20 Reduced 0.22%	9,076 $1.23 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $54,288 - $60,480	-516 Reduced 5.37%	9,096 $1.03 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $60,152 - $66,220	588 Added 6.52%	9,612 $1.04 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $241 - $326	-3 Reduced 0.03%	9,024 $967,000
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $7,388 - $8,671	86 Added 0.96%	9,027 $791,000
Q2 2020 Jul 09, 2020	SELL	$73.37 - $98.18 $7,410 - $9,916	-101 Reduced 1.12%	8,941 $878,000
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $6,127 - $9,290	95 Added 1.06%	9,042 $689,000
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $793 - $992	11 Added 0.12%	8,947 $792,000
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $44,652 - $53,685	709 Added 8.62%	8,936 $677,000
Q2 2019 Aug 01, 2019	BUY	$65.7 - $83.98 $459 - $587	7 Added 0.09%	8,227 $598,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $41,732 - $49,117	541 Added 7.05%	8,220 $662,000
Q4 2018 Jan 17, 2019	BUY	$77.85 - $96.01 $15,569 - $19,202	200 Added 2.67%	7,679 $708,000
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $88,910 - $98,840	-1,000 Reduced 11.79%	7,479 $707,000
Q2 2018 Jul 23, 2018	SELL	$89.78 - $106.23 $15,711 - $18,590	-175 Reduced 2.02%	8,479 $786,000
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $9,385 - $12,567	-102 Reduced 1.16%	8,654 $819,000
Q3 2017 Nov 09, 2017	SELL	$69.85 - $89.22 $20,815 - $26,587	-298 Reduced 3.29%	8,756 $778,000
Q2 2017 Aug 11, 2017	BUY	N/A	9,054	9,054 $657,000

Others Institutions Holding ABBV

# of Institutions

3,654

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diligent Investors, LLC with notifications on news.

Account

Diligent Investors, LLC Abb Vie Inc. Transaction History